Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleBRCAness, SLFN11, and RB1 loss predict response to topoisomerase I inhibitors in triple-negative breast cancers.AuthorsCoussy, Florence; El-Botty, Rania; Château-Joubert, Sophie; Dahmani, Ahmed; Montaudon, Elodie; Leboucher, Sophie; Morisset, Ludivine; Painsec, Pierre; Sourd, Laura; Huguet, Léa; Nemati, Fariba; Servely, Jean-Luc; Larcher, Thibaut; Vacher, Sophie; Briaux, Adrien; Reyes, Cécile; La Rosa, Philippe; Lucotte, Georges; Popova, Tatiana; Foidart, PierreSubjectsTRIPLE-negative breast cancer; DNA topoisomerase IPublicationScience Translational Medicine, 2020, Vol 12, Issue 531, p1ISSN1946-6234Publication typeArticleDOI10.1126/scitranslmed.aax2625